SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Anything graphite based, CCB, Zen and hopefully much more.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pop123 who wrote (2238)4/6/2021 2:29:38 PM
From: the Chief   of 2618
 
The infection side of the ZGS compound is PH1,2,3 human trials

PH1 will be 6 months, + 2 to assemble trial data and submit
PH2 will be 0-12 months and 2-4 months to assemble the data
PH3 will be 12-18 months and 2-4 months to assemble data
4-6 months for HC approval

Assuming you start by September. you are 2.5-3 years from an approval

No idea where you have seen any Biotech complete PH1,2,3 trials in 18 months even if fast tracked
If you can produce an example I would love to see it.

As far as additional data for the mask INK my best guess is you may get away with a 6 month trial but I have never seen an abbreviated trial for anything that can be inhaled including the compounds in nebolizers so this is all new territory. It could be a "special 6 month trial" but if not its at least the 18 months you thought could be done for the ZGS compound

If ZEN does not come up with a revenue stream quickly considering its expenses thus far and expenses committed to in leases etc....I would say they will have to go another year+ without any revenues.

So the PP closing is imperative, hence I short right after the close of that PP
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext